Photo from wikipedia
Low‐dose aspirin (LDA) prophylaxis has been shown to reduce women’s preeclampsia risk. Evidence regarding LDA adherence rates of pregnant women is based almost exclusively on clinical trials, giving a potentially… Click to show full abstract
Low‐dose aspirin (LDA) prophylaxis has been shown to reduce women’s preeclampsia risk. Evidence regarding LDA adherence rates of pregnant women is based almost exclusively on clinical trials, giving a potentially biased picture. Moreover, these studies do not report on determinants of adherence. Since 2017, obstetric healthcare professionals in a Dutch region have assessed women’s preeclampsia risk by means of a prediction tool and counseled those with an above‐population average risk on LDA as a prophylactic measure.
Journal Title: Acta Obstetricia et Gynecologica Scandinavica
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!